BAYRY Relative Valuation - Bayer AG

Watchlist Manager

Watchlist

Price: 11.06 USD 1.28%

Market Cap: $43.5B

B	Bayer AG OTC:BAYRY	DE
M	Mahindra and Mahindra Ltd BSE:500520	IN
	Yamaichi Electronics Co Ltd TSE:6941	JP
	Kinatico Ltd ASX:KYP	AU
	Central Sports Co Ltd TSE:4801	JP
	Acesian Partners Ltd SGX:5FW	SG
	Synnex Technology International Corp TWSE:2347	TW
	BP PLC NYSE:BP	UK
N	Ningbo Shanshan Co Ltd SSE:600884	CN
	Lumentum Holdings Inc NASDAQ:LITE	US
N	Nissui Corp SWB:71N	JP
	K&S Corporation Ltd ASX:KSC	AU
	Wynnstay Properties PLC LSE:WSP	UK
	Geomatec Co Ltd TSE:6907	JP

Multiples-Based Value

The Multiples-Based Value of one BAYRY stock under the Base Case scenario is hidden USD. Compared to the current market price of 11.06 USD, Bayer AG is hidden .

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

What is Relative Valuation?

How is Multiples-Based Value calculated?

BAYRY Multiples-Based Value

Unlock

Worst Case

Base Case

Best Case

Valuation Multiples

View Details

Multiples Across Competitors

All Multiples

P/S

P/E

EV/EBITDA

EV/EBIT

Forward Multiples

			Market Cap	P/S	P/E	EV/EBITDA	EV/EBIT
DE		Bayer AG OTC:BAYRY	37.6B USD	0.8	-10.5	6.5	9.2
US		Eli Lilly and Co NYSE:LLY	829.8B USD	12.9	40.7	27.5	29.4
US		Johnson & Johnson NYSE:JNJ	579B USD	6.2	21.8	15.1	18.6
CH		Roche Holding AG SIX:ROG	248.4B CHF	4	19.3	11.5	12.9
US		Merck & Co Inc NYSE:MRK	296B USD	4.5	16.1	10	12.2
UK		AstraZeneca PLC LSE:AZN	221.8B GBP	5.2	29.9	16.5	23.3
CH		Novartis AG SIX:NOVN	228.6B CHF	5.3	21.2	13.1	16.9
IE	E	Endo International PLC LSE:0Y5F	237.1B USD	102.3	-81.1	375.3	941.3
DK		Novo Nordisk A/S CSE:NOVO B	1T DKK	3.3	10	7.5	8.7
US		Pfizer Inc NYSE:PFE	153.7B USD	2.5	20	7.7	10.3
US		Bristol-Myers Squibb Co NYSE:BMY	117.8B USD	2.5	17	7.2	8.8

				Revenue Growth	P/S to Growth
DE		Bayer AG OTC:BAYRY	Average P/S: 13.6 0.8	3%	0.3
US		Eli Lilly and Co NYSE:LLY	12.9	19%	0.7
US		Johnson & Johnson NYSE:JNJ	6.2	6%	1
CH		Roche Holding AG SIX:ROG	4	4%	1
US		Merck & Co Inc NYSE:MRK	4.5	5%	0.9
UK		AstraZeneca PLC LSE:AZN	5.2	7%	0.7
CH		Novartis AG SIX:NOVN	5.3	5%	1.1
IE	E	Endo International PLC LSE:0Y5F	102.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	3.3	2%	1.7
US		Pfizer Inc NYSE:PFE	2.5	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	2.5	-5%	N/A

				Earnings Growth	PEG
DE		Bayer AG OTC:BAYRY	Average P/E: 21.8 Negative Multiple: -10.5	N/A	N/A
US		Eli Lilly and Co NYSE:LLY	40.7	32%	1.3
US		Johnson & Johnson NYSE:JNJ	21.8	7%	3.1
CH		Roche Holding AG SIX:ROG	19.3	14%	1.4
US		Merck & Co Inc NYSE:MRK	16.1	14%	1.2
UK		AstraZeneca PLC LSE:AZN	29.9	26%	1.2
CH		Novartis AG SIX:NOVN	21.2	14%	1.5
IE	E	Endo International PLC LSE:0Y5F	Negative Multiple: -81.1	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	10	1%	10
US		Pfizer Inc NYSE:PFE	20	22%	0.9
US		Bristol-Myers Squibb Co NYSE:BMY	17	16%	1.1

				EBITDA Growth	EV/EBITDA to Growth
DE		Bayer AG OTC:BAYRY	Average EV/EBITDA: 45.3 6.5	1%	6.5
US		Eli Lilly and Co NYSE:LLY	27.5	22%	1.3
US		Johnson & Johnson NYSE:JNJ	15.1	2%	7.6
CH		Roche Holding AG SIX:ROG	11.5	6%	1.9
US		Merck & Co Inc NYSE:MRK	10	3%	3.3
UK		AstraZeneca PLC LSE:AZN	16.5	13%	1.3
CH		Novartis AG SIX:NOVN	13.1	5%	2.6
IE	E	Endo International PLC LSE:0Y5F	375.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	7.5	1%	7.5
US		Pfizer Inc NYSE:PFE	7.7	-9%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	7.2	-10%	N/A

				EBIT Growth	EV/EBIT to Growth
DE		Bayer AG OTC:BAYRY	Average EV/EBIT: 99.2 9.2	3%	3.1
US		Eli Lilly and Co NYSE:LLY	29.4	22%	1.3
US		Johnson & Johnson NYSE:JNJ	18.6	6%	3.1
CH		Roche Holding AG SIX:ROG	12.9	6%	2.1
US		Merck & Co Inc NYSE:MRK	12.2	6%	2
UK		AstraZeneca PLC LSE:AZN	23.3	21%	1.1
CH		Novartis AG SIX:NOVN	16.9	9%	1.9
IE	E	Endo International PLC LSE:0Y5F	941.3	N/A	N/A
DK		Novo Nordisk A/S CSE:NOVO B	8.7	2%	4.4
US		Pfizer Inc NYSE:PFE	10.3	-4%	N/A
US		Bristol-Myers Squibb Co NYSE:BMY	8.8	-7%	N/A

Bayer AG
OTC:BAYRY

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

BAYRY Competitors Multiples
Bayer AG Competitors

See Also

Company

Help

Tools

Stocks

Bayer AG OTC:BAYRY

Multiples-Based Value

Valuation Multiples

Multiples Across Competitors

BAYRY Competitors Multiples Bayer AG Competitors

See Also

Company

Help

Tools

Stocks

Bayer AG
OTC:BAYRY

BAYRY Competitors Multiples
Bayer AG Competitors